skip to main content

Secondary prevention after MI — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateCardiovascular TherapeuticsSecondary prevention after MIGPhC CRA

A 57-year-old man discharged after myocardial infarction presents with aspirin, atorvastatin, ramipril and bisoprolol. He says he feels well and wants to stop the medicines after one month. What is the most appropriate action?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: A — Explain their secondary-prevention role and encourage continuation as prescribed

Medicines after myocardial infarction reduce the risk of further cardiovascular events and are not prescribed merely for short-term symptom relief. The patient should understand the purpose of each medicine and common adverse effects that warrant review. Stopping early without clinical review may increase risk. A pharmacist should reinforce adherence and refer if side effects or concerns are driving non-adherence.

Reference: BNF; NICE CKS